About ABL Diagnostics
ABL Diagnostics is a company based in Suresnes (France) founded in 2009 was acquired by Advanced Biological Laboratories in October 2021. It operates as a HealthTech and Professional Services. ABL Diagnostics offers products and services including DeepChek® Assay, UltraGene Assay, and Nadis®.
- Headquarter Suresnes, France
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abl Diagnostics S.A.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Advanced Biological Laboratories
(Oct 10, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ABL Diagnostics
ABL Diagnostics offers a comprehensive portfolio of products and services, including DeepChek® Assay, UltraGene Assay, and Nadis®.
Whole genome HIV-1 genotyping is provided through sequencing.
SARS-CoV-2 detection and screening are enabled via RT-PCR.
Electronic medical records are managed with this software.
Funding Insights of ABL Diagnostics
Detailed funding history for ABL Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ABL Diagnostics
ABL Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Advanced Biological Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Digital tools for infectious disease management are offered to providers.
|
Locked | Locked | Locked |
Investor details for ABL Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ABL Diagnostics
Investment portfolio details for ABL Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ABL Diagnostics
Detailed financials for ABL Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abl Diagnostics Comparisons
Peer comparison for ABL Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ABL Diagnostics
Detailed competitors of ABL Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abl Diagnostics
Complete news archive for ABL Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABL Diagnostics
ABL Diagnostics was founded in 2009.
ABL Diagnostics is headquartered in Suresnes, France. It is registered at Suresnes, Ile-de-france, France.
ABL Diagnostics S.A. is focused on improving disease management through innovative microbiology solutions. Products and services are offered in the field of molecular diagnostics, including genotyping assays for viruses like HIV and SARS-CoV-2, real-time PCR assays for detection and quantification, and digital solutions for lab automation and data hosting. The company serves the healthcare sector by providing tools for respiratory, hepatitis, and sexually transmitted infections, among others. Instruments and consumables for DNARNA extraction and sequencing are also supplied to support clinical and research applications.
ABL Diagnostics offers DeepChek® Assay, UltraGene Assay, and Nadis®.
ABL Diagnostics has 1 investor. Key investors include Advanced Biological Laboratories.